Concepedia

Amogh Boloor

AB

Statistics

Publications

6

Citations

967

H-Index

6

Active since

2003

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

Amogh Boloor is an author at GlaxoSmithKline (United States) specializing in drug design, medicinal chemistry, and pharmacology.

Publications per year

2003–2018

6

Publications

6

Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity

Rakesh Kumar, Victoria B. Knick, Sharon K. Rudolph et al. · Molecular Cancer Therapeutics · 2007 · 517 citations

, , +17

Discovery of 5-[[4-[(2,3-Dimethyl-2<i>H</i>-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor

Philip A. Harris, Amogh Boloor, Mui Cheung et al. · Journal of Medicinal Chemistry · 2008 · 345 citations · Full text

, , +15

Efficient and Regioselective Synthesis of 2-Alkyl-2<i>H</i>-indazoles

Mui Cheung, Amogh Boloor, Jeffrey A. Stafford · The Journal of Organic Chemistry · 2003 · 63 citations

, , +9

Synthesis and antiviral activity of HCV NS3/4A peptidomimetic boronic acid inhibitors

Amogh Boloor, Denise Hanway, Maria Joshi et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 20 citations

, , +12

Structure-based optimization of 1H-imidazole-2-carboxamides as Axl kinase inhibitors utilizing a Mer mutant surrogate

Walter Keung, Amogh Boloor, Jason W. Brown et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 12 citations · Full text

, , +17

1–5 of 6